Quarterly Result2 Feb 2026, 03:30 pm
Syschem India Ltd. Announces Q3 Results with 189.84% YoY Growth and Approves Expansion of Existing Plant Units
AI Summary
Syschem India Ltd. announced its unaudited financial results for the quarter and nine months ended 31st December, 2025. The company reported an impressive YoY growth of 189.84% in profit before tax. The Board also approved the expansion of existing plant units, which includes the addition of a new manufacturing unit for Amoxicillin and Ampicillin, and further expansion of the existing CDF unit. The expansion is expected to significantly enhance the company's manufacturing capacity, operational efficiency, and environmental management capabilities.
Key Highlights
- Unaudited financial results for Q3 and nine months ended 31st December, 2025 approved
- Profit before tax (PBT) grew by 189.84% YoY
- Board approved expansion of existing plant units
- Addition of a new manufacturing unit for Amoxicillin and Ampicillin
- Further expansion of existing CDF unit for Cloxacillin Sodium, Dicloxacillin Sodium, and Flucloxacillin Sodium